Skip to Main Content

Author Details

Yongsheng Li
Harbin Medical University
2011
99
29
PMIDPaper TitleJournal TitlePublished Year
36265133Landscape of MicroRNA Regulatory Network Architecture and Functional Rerouting in Cancer.Cancer Res2023
38028194Systematic analysis of DNA methylation-mediated TF dysregulation on lncRNAs reveals critical roles in tumor immunity.Mol Ther Nucleic Acids2023
37651591Systematical analyses of large-scale transcriptome reveal viral infection-related genes and disease comorbidities.Artif Cells Nanomed Biotechnol2023
37500893Deep immunophenotyping reveals clinically distinct cellular states and ecosystems in large-scale colorectal cancer.Commun Biol2023
37273782Landscape and perturbation of enhancer-driven core transcription regulatory circuits in cancer.Mol Ther Nucleic Acids2023
37474972Correction: MIR22HG acts as a tumor suppressor via TGFβ/SMAD signaling and facilitates immunotherapy in colorectal cancer.Mol Cancer2023
37091230Prioritizing exhausted T cell marker genes highlights immune subtypes in pan-cancer.iScience2023
36805221Multi-omics characterization of RNA binding proteins reveals disease comorbidities and potential drugs in COVID-19.Comput Biol Med2023
36685392Dynamic transcriptome analyses reveal m<sup>6</sup>A regulated immune non-coding RNAs during dengue disease progression.Heliyon2023
36681772Single-cell RNA binding protein regulatory network analyses reveal oncogenic HNRNPK-MYC signalling pathway in cancer.Commun Biol2023
36533638Clinical and genomic characterization of mutational signatures across human cancers.Int J Cancer2023
36632748Spatial transcriptome analysis of long non-coding RNAs reveals tissue specificity and functional roles in cancer.J Zhejiang Univ Sci B2023
36271790ImmCluster: an ensemble resource for immunology cell type clustering and annotations in normal and cancerous tissues.Nucleic Acids Res2023
36099422IEAtlas: an atlas of HLA-presented immune epitopes derived from non-coding regions.Nucleic Acids Res2023
34570220TransLnc: a comprehensive resource for translatable lncRNAs extends immunopeptidome.Nucleic Acids Res2022
35614079Pan-cancer analyses reveal the genetic and pharmacogenomic landscape of transient receptor potential channels.NPJ Genom Med2022
35766188Dynamic immune ecosystem of dengue infection revealed by single-cell sequencing.J Leukoc Biol2022
35603200Pediatric Pan-Central Nervous System Tumor Methylome Analyses Reveal Immune-Related LncRNAs.Front Immunol2022
35722704PRES: a webserver for decoding the functional perturbations of RNA editing sites.Brief Bioinform2022
35356543Comprehensive characterization of human-virus protein-protein interactions reveals disease comorbidities and potential antiviral drugs.Comput Struct Biotechnol J2022
36463330Surveying lncRNA-lncRNA cooperations reveals dominant effect on tumor immunity cross cancers.Commun Biol2022
36461099Pan-cancer illumination of TRIM gene family reveals immunology regulation and potential therapeutic implications.Hum Genomics2022
36461064Data analysis guidelines for single-cell RNA-seq in biomedical studies and clinical applications.Mil Med Res2022
36420558HCDT: an integrated highly confident drug-target resource.Database (Oxford)2022
36071454Long noncoding RNA LINC01132 enhances immunosuppression and therapy resistance via NRF1/DPP4 axis in hepatocellular carcinoma.J Exp Clin Cancer Res2022
36352214Bioinformatics Methods for Modeling microRNA Regulatory Networks in Cancer.Adv Exp Med Biol2022
35189633Shedding light on the hidden human proteome expands immunopeptidome in cancer.Brief Bioinform2022
35061901Pan-cancer assessment of mutational landscape in intrinsically disordered hotspots reveals potential driver genes.Nucleic Acids Res2022
32363380CeRNASeek: an R package for identification and analysis of ceRNA regulation.Brief Bioinform2021
33855356mi-IsoNet: systems-scale microRNA landscape reveals rampant isoform-mediated gain of target interaction diversity and signaling specificity.Brief Bioinform2021
33575259Dynamic Expression of m<sup>6</sup>A Regulators During Multiple Human Tissue Development and Cancers.Front Cell Dev Biol2021
33537074Systematic analysis of enhancer regulatory circuit perturbation driven by copy number variations in malignant glioma.Theranostics2021
33557819Pan-cancer characterization of expression and clinical relevance of m<sup>6</sup>A-related tissue-elevated long non-coding RNAs.Mol Cancer2021
34380633Oncostatin M Receptor-Targeted Antibodies Suppress STAT3 Signaling and Inhibit Ovarian Cancer Growth.Cancer Res2021
34755873ImmReg: the regulon atlas of immune-related pathways across cancer types.Nucleic Acids Res2021
34249108Editorial: Perturbation of RNA Binding Protein Regulation in Cancer.Front Genet2021
34247194Identification of a seven-long non-coding RNA signature associated with Jab1/CSN5 in predicting hepatocellular carcinoma.Cell Death Discov2021
33996260Alternative splicing perturbation landscape identifies RNA binding proteins as potential therapeutic targets in cancer.Mol Ther Nucleic Acids2021
33341125RBP EIF2S2 Promotes Tumorigenesis and Progression by Regulating MYC-Mediated Inhibition via FHIT-Related Enhancers.Mol Ther2021
32778890SurvivalMeth: a web server to investigate the effect of DNA methylation-related functional elements on prognosis.Brief Bioinform2021
29738884Pathway perturbations in signaling networks: Linking genotype to phenotype.Semin Cell Dev Biol2020
32081859Pan-cancer characterization of immune-related lncRNAs identifies potential oncogenic biomarkers.Nat Commun2020
32002550Complex impact of DNA methylation on transcriptional dysregulation across 22 human cancer types.Nucleic Acids Res2020
33319172Revealing Epigenetic Factors of circRNA Expression by Machine Learning in Various Cellular Contexts.iScience2020
32606298The interaction between ferroptosis and lipid metabolism in cancer.Signal Transduct Target Ther2020
32855206Integrated Genomic Characterization of the Human Immunome in Cancer.Cancer Res2020
32893032The Atlas of Inflammation Resolution (AIR).Mol Aspects Med2020
32193291LncSpA: LncRNA Spatial Atlas of Expression across Normal and Cancer Tissues.Cancer Res2020
32127004MIR22HG acts as a tumor suppressor via TGFβ/SMAD signaling and facilitates immunotherapy in colorectal cancer.Mol Cancer2020
29077860Systematic review of computational methods for identifying miRNA-mediated RNA-RNA crosstalk.Brief Bioinform2019
  • 1 - 50 of 99

Recommended Authors

Sylvester Comprehensive Cancer Center, University of Miami
Career Start Year 2017
Number of shared co-authors 1
University of Miami Miller School of Medicine
Career Start Year 2016
Number of shared co-authors 0
Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine
Career Start Year 2015
Number of shared co-authors 8
Adaptive Biotechnologies
Career Start Year 2014
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 2011
Number of shared co-authors 3
Mayo Clinic
Career Start Year 2010
Number of shared co-authors 0
Wellcome Sanger Institute
Career Start Year 2009
Number of shared co-authors 0
RIKEN Center for Integrative Medical Sciences
Career Start Year 2009
Number of shared co-authors 0
Center for Global Health, School of Public Health, Nanjing Medical University
Career Start Year 2009
Number of shared co-authors 0
National Institute of Data Science in Health and Medicine, Xiamen University
Career Start Year 2008
Number of shared co-authors 0
University of Michigan ann arbor
Career Start Year 2007
Number of shared co-authors 0
College of Bioinformatics Science and Technology, Harbin Medical University
Career Start Year 2007
Number of shared co-authors 0
Quantitative Biomedical Research Center
Career Start Year 2007
Number of shared co-authors 2
Greehey Children's Cancer Research Institute
Career Start Year 2007
Number of shared co-authors 7
Center for Precision Health, The University of Texas Health Science Center at Houston
Career Start Year 2006
Number of shared co-authors 7
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 2006
Number of shared co-authors 3
Washington University in St Louis
Career Start Year 2006
Number of shared co-authors 3
St. Jude Children's Research Hospital
Career Start Year 2006
Number of shared co-authors 3
Baylor College of Medicine
Career Start Year 2005
Number of shared co-authors 0
David Geffen School of Medicine, University of California at Los Angeles
Career Start Year 2004
Number of shared co-authors 3
University of Tennessee Health Science Center
Career Start Year 2004
Number of shared co-authors 6
Pfizer Inc.
Career Start Year 2004
Number of shared co-authors 0
Present address: Dxige Research Inc.
Career Start Year 2003
Number of shared co-authors 8
Baylor College of Medicine
Career Start Year 2003
Number of shared co-authors 1
Hospital Sirio Libanes
Career Start Year 2003
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute
Career Start Year 2002
Number of shared co-authors 0
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 3
The University of Texas Health Science Center at San Antonio
Career Start Year 2001
Number of shared co-authors 0
Medical Center - University of Freiburg, University of Freiburg
Career Start Year 1999
Number of shared co-authors 1
Center for Precision Health, The University of Texas Health Science Center at Houston
Career Start Year 1998
Number of shared co-authors 8

Collaborators

College of Bioinformatics Science and Technology, Harbin Medical University
Co-authored papers 71
The University of Texas MD Anderson Cancer Center
Co-authored papers 14
Livestrong Cancer Institutes, Dell Medical School, The University of Texas at Austin
Co-authored papers 13
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 9
Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic
Co-authored papers 8
The University of Texas MD Anderson Cancer Center
Co-authored papers 4
Co-authored papers 3
University of Texas MD Anderson Cancer Center
Co-authored papers 2
Institute of Enzymology, HUN-REN Research Centre for Natural Sciences
Co-authored papers 2
St. Jude Children's Research Hospital
Co-authored papers 2
Livestrong Cancer Institutes, Dell Medical School, The University of Texas at Austin
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Co-authored papers 1
Stem Cell Translational Research Center of Tongji Hospital, Tongji University
Co-authored papers 1
MD Anderson Cancer Center
Co-authored papers 1
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
Children's Hospital of Philadelphia
Co-authored papers 1
Zhengzhou University
Co-authored papers 1
Institute for Cancer Genetics, Columbia University Irving Medical Center
Co-authored papers 1
Institute for Research in Immunology and Cancer, Universite de Montreal
Co-authored papers 1
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers 1
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
Johns Hopkins University
Co-authored papers 1
Johns Hopkins University School of Medicine
Co-authored papers 1
Life Sciences Institute, Zhejiang University
Co-authored papers 1
Washington University in St. Louis
Co-authored papers 1
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
University of Texas MD Anderson Cancer Center
Co-authored papers 1
Asan Medical Center, University of Ulsan College of Medicine
Co-authored papers 1